BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19477404)

  • 21. Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.
    Laukkanen JA; Mäkikallio TH; Kauhanen J; Kurl S
    Am Heart J; 2009 Oct; 158(4):615-21. PubMed ID: 19781422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.
    Du Preez J; Matolweni LO; Greenberg J; Mntla P; Adeyemo AA; Mayosi BM
    Cardiovasc J Afr; 2008; 19(1):15-6. PubMed ID: 18320080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
    White HL; de Boer RA; Maqbool A; Greenwood D; van Veldhuisen DJ; Cuthbert R; Ball SG; Hall AS; Balmforth AJ;
    Eur J Heart Fail; 2003 Aug; 5(4):463-8. PubMed ID: 12921807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norepinephrine transporter and alpha(2c) adrenoceptor allelic variants and personality factors.
    Tsai SJ; Wang YC; Hong CJ
    Am J Med Genet; 2002 Aug; 114(6):649-51. PubMed ID: 12210281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Meisel C; Köpke K; Roots I
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12556550
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatment.
    Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Hjelvang BR; Henriksen T; Frandsen E; Forman JL; Torp-Pedersen C; Køber L; Poulsen HE
    Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):779-85. PubMed ID: 22703382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure.
    Bristow MR; Murphy GA; Krause-Steinrauf H; Anderson JL; Carlquist JF; Thaneemit-Chen S; Krishnan V; Abraham WT; Lowes BD; Port JD; Davis GW; Lazzeroni LC; Robertson AD; Lavori PW; Liggett SB
    Circ Heart Fail; 2010 Jan; 3(1):21-8. PubMed ID: 19880803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
    Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
    J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
    Ohlin B; Berglund G; Nilsson PM; Melander O
    J Hypertens; 2008 Aug; 26(8):1583-9. PubMed ID: 18622236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
    Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
    Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.
    Aleong RG; Sauer WH; Davis G; Murphy GA; Port JD; Anand IS; Fiuzat M; O'Connor CM; Abraham WT; Liggett SB; Bristow MR
    JACC Heart Fail; 2013 Aug; 1(4):338-344. PubMed ID: 24159564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis.
    Kitsios G; Zintzaras E
    Am J Epidemiol; 2007 Sep; 166(6):619-33. PubMed ID: 17644825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.
    Mialet Perez J; Rathz DA; Petrashevskaya NN; Hahn HS; Wagoner LE; Schwartz A; Dorn GW; Liggett SB
    Nat Med; 2003 Oct; 9(10):1300-5. PubMed ID: 14502278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between AT1R gene polymorphism and long-term outcome in patients with heart failure.
    Amir O; Amir RE; Paz H; Attias E; Sagiv M; Lewis BS
    Cardiology; 2009; 112(2):151-7. PubMed ID: 18612202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.